Leaderboards/Thyroid Cancer Diagnosis and Treatment

Thyroid Cancer Diagnosis and Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Lucas Kallas-Silva
Universidade Federal de São Paulo
2
Haifan Gong
Chinese University of Hong Kong, Shenzhen
3
Chantal A Lebbink
University Medical Center Utrecht
4
Sandeep Kumar Parvathareddy
King Faisal Specialist Hospital & Research Centre
5
Andreas Schindele
University of Augsburg
6
Joanna Kochman
Pomeranian Medical University
7
Tommaso Porcelli
University of Naples Federico II
8
Elizabeth J. de Koster
Radboud University Nijmegen
9
Barbora Pekova
Institute of Endocrinology
10
Angelika Buczyńska
Medical University of Białystok

Papers

1
Examining the clinical relevance of metformin as an antioxidant intervention
Frontiers in Pharmacology|2024
59 cit.
2
Nnmamba: 3D Biomedical Image Segmentation, Classification and Landmark Detection with State Space Model
Unknown Journal|2025
59 cit.
3
Publication in European Journal of Radiology (2025) [42 citations, W4408446202]
European Journal of Radiology|2025
42 cit.
4
Publication in Endocrine (2024) [7 citations, W4396597760]
Endocrine|2024
7 cit.
5
Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer Via a Biomarker Panel Involving TAC, 8-OHdG, and Sortilin
The Journal of Clinical Endocrinology & Metabolism|2024
6 cit.
6
Boundary as the Bridge: Toward Heterogeneous Partially-Labeled Medical Image Segmentation and Landmark Detection
IEEE Transactions on Medical Imaging|2025
6 cit.
7
Metformin modulates oxidative stress via activation of AMPK/NF-κB signaling in Trisomy 21 fibroblasts: an in vitro study
Frontiers in Molecular Biosciences|2025
6 cit.
8
Identification of MicroRNA Profiles in Fetal Spina Bifida: The Role in Pathomechanism and Diagnostic Significance
International Journal of Molecular Sciences|2024
4 cit.
9
Publication in Journal of Clinical Medicine (2024) [3 citations, W4393142668]
Journal of Clinical Medicine|2024
3 cit.
10
Publication in Frontiers in Endocrinology (2024) [3 citations, W4396937106]
Frontiers in Endocrinology|2024
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Ming-An Yu
Chinese Academy of Medical Sciences & Peking Union Medical College
2
Yukun Luo
Chinese PLA General Hospital
3
Jun Xiang
Huazhong University of Science and Technology
4
Jianqiao Zhou
Shanghai Jiao Tong University
5
Min Ji Jeon
Ulsan College
6
Eun Ju Ha
Ajou University
7
Xinliang Su
The Affiliated Yongchuan Hospital of Chongqing Medical University
8
Masha J. Livhits
University of California, Los Angeles
9
Zou Bao
Anhui University
10
Yukun Luo
Chinese PLA General Hospital

Papers

1
Microwave Ablation versus Surgical Resection for Solitary T1N0M0 Papillary Thyroid Carcinoma
Radiology|2022
84 cit.
2
Long-Term Outcomes and Risk Factors of Radiofrequency Ablation for T1N0M0 Papillary Thyroid Carcinoma
JAMA Surgery|2023
71 cit.
3
Virtual elastography ultrasound via generative adversarial network for breast cancer diagnosis
Nature Communications|2023
49 cit.
4
Recurrent Laryngeal Nerve Injury in Thermal Ablation of Thyroid Nodules—Risk Factors and Cause Analysis
The Journal of Clinical Endocrinology & Metabolism|2022
47 cit.
5
Artificial Intelligence Model Assisting Thyroid Nodule Diagnosis and Management: A Multicenter Diagnostic Study
The Journal of Clinical Endocrinology & Metabolism|2023
44 cit.
6
Microwave Ablation versus Surgical Resection for US-detected Multifocal T1N0M0 Papillary Thyroid Carcinoma: A 10-Center Study
Radiology|2024
41 cit.
7
Long-term Outcomes of Ultrasound-guided Thermal Ablation for the Treatment of Solitary Low-risk Papillary Thyroid Microcarcinoma
Annals of Surgery|2023
39 cit.
8
Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer
JAMA Otolaryngology–Head & Neck Surgery|2023
38 cit.
9
Clinical outcomes of ultrasound‐guided radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma: A retrospective study with more than 5 years of follow‐up
Cancer|2023
37 cit.
10
Bethesda III and IV Thyroid Nodules Managed Nonoperatively After Molecular Testing With Afirma GSC or Thyroseq v3
The Journal of Clinical Endocrinology & Metabolism|2023
36 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
R. Michael Tuttle
Memorial Sloan Kettering Cancer Center
2
Martin Schlumberger
Institut Gustave Roussy
3
Yuri E. Nikiforov
University of Pittsburgh Medical Center
4
Akira Miyauchi
Kuma Hospital
5
James A. Fagin
Memorial Sloan Kettering Cancer Center
6
Henning Dralle
Regio Kliniken
7
H. Gilbert Welch
Brigham and Women's Hospital
8
Mingzhao Xing
Johns Hopkins University
9
Jung Hwan Baek
Ulsan College
10
Ronald Ghossein
Memorial Sloan Kettering Cancer Center

Papers

1
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid|2009
6.8k cit.
2
Increasing Incidence of Thyroid Cancer in the United States, 1973-2002
JAMA|2006
3.4k cit.
3
Lenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
New England Journal of Medicine|2015
2.1k cit.
4
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
Thyroid|2006
2k cit.
5
Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy
The Journal of Clinical Endocrinology & Metabolism|2006
1.7k cit.
6
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
The Lancet|2014
1.6k cit.
7
Current Thyroid Cancer Trends in the United States
JAMA Otolaryngology–Head & Neck Surgery|2014
1.6k cit.
8
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
Journal of Clinical Oncology|2011
1.6k cit.
9
High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma.
PubMed|2003
1.5k cit.
10
Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma
JAMA Oncology|2016
1.4k cit.

Reagents for Thyroid Cancer Diagnosis and Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Beckman Coulter

Access Free T4 kit

Cited in 6 papers
#33880
View Evidence →
Agilent/Dako

Calcitonin

Cited in 6 papers
#A0576
View Evidence →
Cell Signaling TechnologyEvidence 65

Phospho-ATP-Citrate Lyase (Ser455) Antibody

Cited in 6 papers
#4331$148,362
View Evidence →

🌟 All-Time

Most validated

Abcam

Anti-BRAF (mutated V600E) antibody [VE1]

Cited in 10 papers
#ab228461
View Evidence →
Cell Signaling TechnologyEvidence 65

CYP17A1 (E6A7G) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 8 papers
#49449$865
View Evidence →
Cell Signaling Technology

Neurogenin 2 (D2R3D) Rabbit Monoclonal Antibody

Cited in 6 papers
#13144$157,348
View Evidence →